US FDA Classifies Eugia Pharma’s Telangana Facility as OAI Following February 2026 Inspection 25/05/2026 / Regulatory Filings / Regulatory Compliance Update US FDA Classifies Eugia Pharma’s Telangana Facility as OAI Following February 2026 Inspection Read Post »
Alembic Pharmaceuticals Receives USFDA EIR for Injectable Facility at Karakhadi 14/05/2026 / Regulatory Filings / Regulatory Compliance Update Alembic Pharmaceuticals Receives USFDA EIR for Injectable Facility at Karakhadi Read Post »
Torrent Pharma Clears USFDA Inspection with Zero Observations at Oncology Facility 10/04/2026 / Material Events / Regulatory Compliance Update Torrent Pharma Clears USFDA Inspection with Zero Observations at Oncology Facility Read Post »
